Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains.

IF 2.4 Q2 HEALTH CARE SCIENCES & SERVICES
Maike G Sweegers, Esther de Jongh, Christopher Bedding, Emma Nicklin, Daniela Doege, Sara Alfieri, Laura Gangeri, Bianca Scacciati, Augusto Caraceni, Cinzia Brunelli, Anne Bredart, Leslye Rojas-Concha, Helle Pappot, Giovanni Apolone, Nanne Bos, Gennaro Ciliberto, Norbert Couespel, Montse Ferrer, Stein Kaasa, Claudio Lombardo, Ricardo Pietrobon, Gabriella Pravettoni, Aude Sirven, Hugo Vachon, Mogens Groenvold, Maria Alice Franzoi, Galina Velikova, Alexandra Gilbert, Lonneke V van de Poll-Franse
{"title":"Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains.","authors":"Maike G Sweegers, Esther de Jongh, Christopher Bedding, Emma Nicklin, Daniela Doege, Sara Alfieri, Laura Gangeri, Bianca Scacciati, Augusto Caraceni, Cinzia Brunelli, Anne Bredart, Leslye Rojas-Concha, Helle Pappot, Giovanni Apolone, Nanne Bos, Gennaro Ciliberto, Norbert Couespel, Montse Ferrer, Stein Kaasa, Claudio Lombardo, Ricardo Pietrobon, Gabriella Pravettoni, Aude Sirven, Hugo Vachon, Mogens Groenvold, Maria Alice Franzoi, Galina Velikova, Alexandra Gilbert, Lonneke V van de Poll-Franse","doi":"10.1186/s41687-025-00907-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cancer and cancer treatment have a major impact on health related quality of life (HRQoL). To improve the assessment of HRQoL in patients with cancer and evaluate the impact of policy interventions, the European Oncology Quality of Life (EUonQoL) project aims at developing a digital, patient centred system to assess HRQoL based on evaluations and preferences of cancer patients and survivors: the EUonQoL-kit.</p><p><strong>Method: </strong>Patients across the cancer care continuum, healthcare professionals and researchers from six European countries (Denmark, France, Germany, Italy, The Netherlands and United Kingdom) were asked to rate the importance of 44 pre-selected HRQoL subdomains over a maximum of three Delphi survey rounds. We evaluated the importance of HRQoL subdomains for three target populations: patients undergoing active treatment, cancer survivors and patients receiving palliative care. The results were discussed during a consensus meeting.</p><p><strong>Results: </strong>96 patients and 59 healthcare professionals participated in the Delphi study. After three rounds, consensus was reached for 20 subdomains: ability to work, communication with healthcare professionals, diarrhoea, fatigue, fear of recurrence, global health status, impact of treatment side effects, impact on children/family, insomnia, instrumental activities of daily living, maintaining independence, mobility, nausea, overall quality of life, pain, partner relationship, social activity limitations, social isolation, symptom awareness and uncertain prognosis. The subdomains pain and fear of recurrence were rated as important for all three target populations.</p><p><strong>Conclusion: </strong>Subdomains that were considered important for the assessment of HRQoL in patients with cancer can be summarised into: physical symptoms, mobility & activity, future outlook, social roles & activities, family & relationships, social isolation, self-efficacy, overall HRQoL, and healthcare experience. The importance of the subdomains differed for patients in different phases of the cancer care continuum. These findings were used for the creation of the first version of the EUonQoL-Kit, as a base for its further development.</p>","PeriodicalId":36660,"journal":{"name":"Journal of Patient-Reported Outcomes","volume":"9 1","pages":"70"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179011/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Patient-Reported Outcomes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41687-025-00907-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cancer and cancer treatment have a major impact on health related quality of life (HRQoL). To improve the assessment of HRQoL in patients with cancer and evaluate the impact of policy interventions, the European Oncology Quality of Life (EUonQoL) project aims at developing a digital, patient centred system to assess HRQoL based on evaluations and preferences of cancer patients and survivors: the EUonQoL-kit.

Method: Patients across the cancer care continuum, healthcare professionals and researchers from six European countries (Denmark, France, Germany, Italy, The Netherlands and United Kingdom) were asked to rate the importance of 44 pre-selected HRQoL subdomains over a maximum of three Delphi survey rounds. We evaluated the importance of HRQoL subdomains for three target populations: patients undergoing active treatment, cancer survivors and patients receiving palliative care. The results were discussed during a consensus meeting.

Results: 96 patients and 59 healthcare professionals participated in the Delphi study. After three rounds, consensus was reached for 20 subdomains: ability to work, communication with healthcare professionals, diarrhoea, fatigue, fear of recurrence, global health status, impact of treatment side effects, impact on children/family, insomnia, instrumental activities of daily living, maintaining independence, mobility, nausea, overall quality of life, pain, partner relationship, social activity limitations, social isolation, symptom awareness and uncertain prognosis. The subdomains pain and fear of recurrence were rated as important for all three target populations.

Conclusion: Subdomains that were considered important for the assessment of HRQoL in patients with cancer can be summarised into: physical symptoms, mobility & activity, future outlook, social roles & activities, family & relationships, social isolation, self-efficacy, overall HRQoL, and healthcare experience. The importance of the subdomains differed for patients in different phases of the cancer care continuum. These findings were used for the creation of the first version of the EUonQoL-Kit, as a base for its further development.

开发一个统一的系统,用于评估癌症治疗连续体中与健康相关的生活质量:EUonQoL德尔菲研究,以确定生活质量领域的优先事项。
癌症和癌症治疗对健康相关生活质量(HRQoL)有重大影响。为了改进对癌症患者HRQoL的评估并评估政策干预的影响,欧洲肿瘤生活质量(EUonQoL)项目旨在开发一个数字化的、以患者为中心的系统,根据癌症患者和幸存者的评估和偏好来评估HRQoL: EUonQoL-kit。方法:来自六个欧洲国家(丹麦、法国、德国、意大利、荷兰和英国)的癌症护理连续体患者、医疗保健专业人员和研究人员被要求对44个预先选择的HRQoL子域的重要性进行评分,最多进行三轮德尔菲调查。我们评估了HRQoL子域对三个目标人群的重要性:接受积极治疗的患者、癌症幸存者和接受姑息治疗的患者。结果在协商一致会议上进行了讨论。结果:96名患者和59名医护人员参与了德尔菲研究。三轮后,对20个子领域达成共识:工作能力、与医护人员的沟通、腹泻、疲劳、对复发的恐惧、整体健康状况、治疗副作用的影响、对儿童/家庭的影响、失眠、日常生活工具活动、保持独立性、行动能力、恶心、整体生活质量、疼痛、伴侣关系、社交活动限制、社交孤立、症状意识和不确定预后。子域疼痛和恐惧复发被认为对所有三个目标人群都很重要。结论:对癌症患者HRQoL评估重要的子领域可归纳为:身体症状、活动能力和活动、未来前景、社会角色和活动、家庭和关系、社会孤立、自我效能、整体HRQoL和医疗体验。在癌症治疗连续体的不同阶段,亚域的重要性是不同的。这些发现被用于创建EUonQoL-Kit的第一个版本,作为其进一步发展的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes Health Professions-Health Information Management
CiteScore
3.80
自引率
7.40%
发文量
120
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信